SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today ...
ClearPoint Neuro, Inc. CLPT recently announced its receipt of the FDA’s clearance and first-in-human cases using the ClearPoint 2.2 Software with integrated Maestro Brain Modeling. The company also ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback